We are monitoring the impact of COVID-19 on Bleeding Disorders Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 3229
Share on
Share on

Global Bleeding Disorders Treatment Market Analysis - By Drug Class (Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates And Plasma-Derived Coagulation Factor Concentrates), By Type (vWD, Hemophilia A, Hemophilia B), By Region - Industry Size, Share, Growth, Trends, And Forecast | 2019-2024

Pulished: August, 2019
ID: 3229
Pages: 181

Bleeding Disorders Treatment Market Size & Growth (2019-2024)

The size of the global bleeding disorders treatment market was worth USD 13 billion in 2019 and is growing at a CAGR of 7.98%, to reach USD 19.1 billion by 2024.

A bleeding disorder is a medical condition that is interfered by blood clotting, which prevents the forming of the blood clot. The common bleeding disorders are like haemophilia, platelets disorders and Von Willebrand diseases and others. Bleeding disorders can cause both internally and externally. Externally is blood flows out from the body when an injury happens. Internal bleeding occurs when the blood continues to flow under the skin like the brain clot. These kinds of issues arise in bleeding disorders. Haemophilia is one of the most occurring bleeding diseases where the blood doesn’t clot out. Von Willebrand disease occurs in women majorly.

In general, the bleeding disorders treatment includes the drugs which help in the treatment and management of the bleeding disorder. It may result in harmful to bleeding and blood clotting and coagulation. 

The treatment includes new frozen plasma, iron supplement and antifibrinolytic drugs. This bleeding disorder can also be hereditary, lack of vitamin K deficiency, reduction of red blood cells, and usage of certain drugs that cause side-effects.

A growing number of patients suffering from bleeding disorders across the globe is driving the demand of the market. Creating awareness over the availability of different treatments is boosting up the growth rate of the market. Bringing out the new medicine or the drugs with the advance technology, which help in preventing the bleeding disorder also leverage the market. Availability of healthcare infrastructure that leads to the iron supplement and blood transfusion is likely to boost up the market. The key player’s investments are growing to reduce the cost of treatment procedures which is also driving the market forward.

High costs associated with the treatment and shortage of expert doctors or surgeons in undeveloped countries are the factors hampering market growth. People having no or minimum knowledge about the bleeding disorder is also hindering the growth. Also, lack of approvals and support of reimbursement policies from the government is likely to hinder the market of bleeding disorder treatment.

Recent Market Developments

On February 10, 2020, Novo Nordisk has made a public statement about the launch of ESPEROCT. It can be used in adults and children to control and treat bleeding during the surgery.

On December 05, 2019, Bayer AG made a public statement that it is going to have a three-year collaboration with the children’s hospital. The development and discovery of small molecules for the treatment of haemophilia A and B is the main motto of this collaboration.  

On September 12, 2018, Shire Plc announced that the Europea Commission EU has received granted marketing authorization for VEYVONDI. It is the first Von Willebrand Factor used for the treatment in adults with bleeding and treats illness. It also helps in preventing bleeding during surgeries.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Drug Class, Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the Global Bleeding Disorders Treatment Market has been segmented and sub-segmented based on drug class, type, and region.

Bleeding Disorders Treatment Market - By Drug Class                   

  • Fibrin Sealant         
  • Desmopressin       
  • Antibrinolytics       
  • Recombinant Coagulation Factor Concentrates     
  • Plasma Derived Coagulation Factor Concentrates  

Based on the drug class, the recombinant coagulation factor concentrates segment is to grow the fastest in the mentioned forecast period. It is because of the increased R&D in this market and the increasing focus of pharmaceutical companies on recombinant products.

Bleeding Disorders Treatment Market - By Type                              

  • vWD           
  • Hemophilia A         
  • Hemophilia B          

Regional Insights

For the upcoming years, Asia-Pacific to grow the fastest in this market followed by Latin America. It is because local governments are becoming more concerned about healthcare in these regions and increasing per capita income in these regions. North America has the most significant market share among all the areas.

Key market leaders in the global bleeding disorders treatment market profiled in the report are:

  • CSL Behring
  • Pfizer Inc.
  • Novo Nordisk
  • Bayer AG
  • Biogen Inc.
  • Shire Plc.
  • Medline Plus
  • Janssen Global Services LLC
  • Grifos SA.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 Fibrin Sealant         

                                5.1.3 Desmopressin       

                                5.1.4 Antibrinolytics       

                                5.1.5 Recombinant Coagulation Factor Concentrates      

                                5.1.6 Plasma Derived Coagulation Factor Concentrates  

                                5.1.7  Y-o-Y Growth Analysis, By Drug Class          

                                5.1.8  Market Attractiveness Analysis, By Drug Class        

                                5.1.9  Market Share Analysis, By Drug Class         

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 vWD           

                                5.2.3 Hemophilia A         

                                5.2.4 Hemophilia B          

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Type

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 CSL Behring                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer Inc.                    

                8.3 Novo Nordisk                            

                8.4 Bayer AG                     

                8.5 Biogen Inc.                  

                8.6 Shire Plc.                      

                8.7 LLC                 

                8.8 Medline Plus                              

                8.9 Janssen Global Services                        

                8.10 Grifos SA                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Bleeding Disorders Treatment Market By Region, From 2019-2024 ( USD Billion )
  2. Global Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  3. Global Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  4. Global Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  5. Global Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  6. Global Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  7. Global Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  8. Global Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  9. Global vWD Market By Region, From 2019-2024 ( USD Billion )
  10. Global Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  11. Global Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  12. North America Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  13. North America Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  14. North America Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  15. North America Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  16. North America Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  17. North America Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  18. North America Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  19. North America vWD Market By Region, From 2019-2024 ( USD Billion )
  20. North America Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  21. North America Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  22. United States Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  23. United States Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  24. Canada Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  25. Canada Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  26. Europe Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  27. Europe Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  30. Europe Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  31. Europe Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  32. Europe Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  33. Europe vWD Market By Region, From 2019-2024 ( USD Billion )
  34. Europe Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  35. Europe Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  36. U.K. Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  37. U.K. Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  38. Germany Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  39. Germany Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  40. France Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  41. France Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  42. Italy Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  43. Italy Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  44. Spain Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  45. Spain Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  46. Asia-Pacific Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  47. Asia-Pacific Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  48. Asia-Pacific Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  49. Asia-Pacific Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  50. Asia-Pacific Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  51. Asia-Pacific Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  52. Asia-Pacific Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  53. Asia-Pacific vWD Market By Region, From 2019-2024 ( USD Billion )
  54. Asia-Pacific Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  55. Asia-Pacific Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  56. Japan Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  57. Japan Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  58. China Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  59. China Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  60. India Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  61. India Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  62. Australia Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  63. Australia Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  64. South Korea Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  65. South Korea Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  66. Latin America Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  67. Latin America Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  68. Latin America Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  69. Latin America Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  70. Latin America Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  71. Latin America Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  72. Latin America Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  73. Latin America vWD Market By Region, From 2019-2024 ( USD Billion )
  74. Latin America Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  75. Latin America Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  76. Brazil Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  77. Brazil Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  78. Argentina Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  79. Argentina Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  80. Mexico Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  81. Mexico Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  82. Rest of Latin America Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  83. Rest of Latin America Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  84. Middle East & Africa Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  85. Middle East & Africa Fibrin Sealant Market By Region, From 2019-2024 ( USD Billion )
  86. Middle East & Africa Desmopressin Market By Region, From 2019-2024 ( USD Billion )
  87. Middle East & Africa Antibrinolytics Market By Region, From 2019-2024 ( USD Billion )
  88. Middle East & Africa Recombinant Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  89. Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  90. Middle East & Africa Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  91. Middle East & Africa vWD Market By Region, From 2019-2024 ( USD Billion )
  92. Middle East & Africa Hemophilia A Market By Region, From 2019-2024 ( USD Billion )
  93. Middle East & Africa Hemophilia B Market By Region, From 2019-2024 ( USD Billion )
  94. Middle East Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  95. Middle East Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )
  96. Africa Bleeding Disorders Treatment Market By Drug Class, From 2019-2024 ( USD Billion )
  97. Africa Bleeding Disorders Treatment Market By Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample